hotspot -WSS

hotspot

author：comprehensive 2025-09-06 04:13:01 - browse：8

foreign-trained health professionals — Adobe

The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process.

The American Hospital Association, the industry’s main lobbying group, told STAT it is “not commenting on this issue right now.” The American Medical Association had no comment and deferred to other physician trade groups. The Federation of American Hospitals offered no statement.

The American Health Care Association, which lobbies on behalf of nursing homes, did not comment on the list of 10 drugs or Medicare’s negotiating power. But it said in a statement that “many nursing home residents have multiple chronic conditions that require several medications, so any efforts at reducing their out-of-pocket costs would be welcome.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Update the Apgar Score to remove skin color

focus

hotspot

WSS

TikTok, Instagram influencers need more rules for drug ads

Dog Aging Project founders on what lies ahead after losing funding

For AI in health care standards, federal regulators join with industry group

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

CVS is on a mission to consolidate health care. Will it work?

For AI in health care standards, federal regulators join with industry group

hotspot

hotspot

leisure time

Hepatitis C has a cure — but many Americans still lack access to it

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Future doctors need a strong humanities education

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Fetal cell organoids grown from amniotic fluid, study finds

After affirmative action ruling, medical educators look to 'holistic review'

For AI in health care standards, federal regulators join with industry group

Jerome Adams on the need for new antivirals for Covid

Medicare bonuses could stop drug shortages under Senate plan

explore

Lack of health data on LGBTQ+ people has serious consequences

Cardiologists urge adding sexual orientation, gender identity to health records

Maisha Meds is a PBM, but don't call it that

The inclusion problem at the heart of rehabilitation research

Dog Aging Project founders on what lies ahead after losing funding

$1 billion proposal to grow Boston, Massachusetts biotech

focus

focus

hotspot

entertainment